Board Changes
Iconic Labs PLC
("Iconic" or the "Company")
Board Changes
Iconic Labs PLC (LSE: ICON) announces that after more than two years of serving as a Director of the Company, Victor Humberdot is stepping down from this position with immediate effect.
The Company would like to thank Mr Humberdot for his support during this period.
The Company also announces the appointment of Bertalan Jászkuti (aged 52) as Director with immediate effect. Bertalan is a health economist and currently serves as Head of Innovation Funding at Syreon Research Institute Ltd. Prior to his current position, he held senior roles focusing on corporate finance advisory, mergers & acquisitions, fundraising and equity capital market transactions including at Deloitte Advisory and Management Consulting where he was for six years, in addition to his own life-sciences focused boutique investment firm. Over the past 25 years Bertalan has served a wide variety of clients including entrepreneurs seeking sales or fundraising as well as institutional private equity funds, private investors and large multinational companies seeking capital deployment. Bertalan completed all exams at the Chartered Association of Certified Accountants (ACCA) and he holds the ICAEW's Corporate Finance (CF) qualification.
For any further information or enquiries please contact:
Iconic Labs
John Farquharson, Chief Executive Officer
via Yellow Jersey PR
AlbR Capital Limited
David Coffman / Daniel Harris
Tel: +44 (0) 20 7469 0930
Yellow Jersey PR
Charles Goodwin
Annabelle Wills
Tel: +44 (0) 20 3004 9512
iconic@yellowjerseypr.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDBOAUPUCAMUPQUAG
